Global Vascular Patches Market Revenue Grows at a CAGR of 7.73%

Introduction

Straits Research released its highly anticipated report, “Global Vascular Patches Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 456.42 million in 2025 and is anticipated to grow to USD 888.94 million by 2034, growing at a CAGR of 7.73% from 2026-2034.

Market Dynamics

The vascular patches market is primarily driven by the steady rise in carotid endarterectomy, abdominal aortic repair, and peripheral vascular reconstruction procedures, supported by earlier diagnosis of vascular disorders and growing adoption of patch-based closure techniques that enhance surgical outcomes. Hospitals and specialty vascular centers are incorporating broader patch portfolios as they expand cardiovascular units and standardize repair pathways, which further accelerates product demand across biologic and synthetic categories. However, the market faces restraint due to variation in surgeon familiarity with newer materials, differences in procurement preferences across institutions, and slower adoption in facilities that continue to rely on traditional closure techniques. These factors can create inconsistencies in product uptake and extend evaluation cycles for both biologic and synthetic patches. Despite these challenges, the market holds a strong opportunity in the rapid expansion of hybrid operating suites and minimally invasive vascular programs, where patches tailored for controlled access points, flexible deployment, and streamlined preparation can gain traction. As healthcare systems continue to upgrade surgical infrastructure and diversify vascular treatment models, demand for advanced patch formats that align with evolving clinical practices is expected to grow.

Market Highlights

• Material: Based on Material, Synthetic vascular patches represent the fastest-growing segment of 8.12% during the forecast period.
• Application: Based on Application, Carotid endarterectomy dominated the market with a revenue share of 65.05%.
• End User: Based on End User, Ambulatory Surgical Centers (ASCs) are the fastest-growing end-user segment with a CAGR of 8.63% during the forecast period.
• Regional Insights: North America dominated the market with 73% of market share in 2025.

Competitive Players

1. Baxter
2. LeMaitre Vascular, Inc.
3. L. Gore & Associates, Inc.
4. Getinge AB
5. Terumo Corporation
6. Medical Device Business Services, Inc.
7. Edwards Lifesciences Corporation
8. Artivion, Inc
9. Medtronic
10. Labcor Laboratórios Ltda.
11. Vascumed (Pty) Ltd
12. Insitu
13. Braun SE 
14. Neovasc Inc.
15. Others

Recent Developments

April 2025: LeMaitre Vascular, Inc. reported in its Q1 2025 financial disclosures that its biologic vascular product Artegraft received the MDR CE Mark on April 29, 2025, clearing the product for commercial distribution across Europe under the new EU regulatory framework.

Segmentation

1. By Material (2026-2034)
   1. Biologic Vascular Patches
   2. Synthetic Vascular Patches
2. By Application (2026-2034)
   1. Carotid Endarterectomy
   2. Open Repair of Abdominal Aortic Aneurysms
   3. Other Applications
3. By End User (2026-2034)
   1. Hospitals & Clinics
   2. Ambulatory Surgical Centers